UM/UIM Claims and Pharmacy Documentation: A National Guide for PI Attorneys

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | December 22, 2025 | 10 min read

Uninsured and underinsured motorist claims are won on documentation — because the UM/UIM carrier is the client's own insurer, and they fight hard. Pharmacy records are especially important in UM/UIM cases: they document injury severity to an adversarial carrier who has every financial incentive to deny or minimize the claim.

UM/UIM Claims and Pharmacy Documentation: A National Guide for PI Attorneys

Uninsured motorist (UM) and underinsured motorist (UIM) claims present a unique dynamic: the attorney is fighting their own client's insurance company. Unlike a third-party liability claim against a stranger's insurer, UM/UIM puts the plaintiff in adversarial posture with a carrier that ostensibly exists to protect the client — but has every financial incentive to minimize the payout.

In this environment, the quality and completeness of medical documentation — including pharmacy records — is decisive. UM/UIM carriers have sophisticated claims operations with high-volume IME programs and experienced staff adjusters who know how to challenge documentation gaps.

[!KEY] In UM/UIM cases, a continuous pharmacy record showing multi-system prescriptions over 12 or more months is objective third-party documentation of injury severity that is harder for the carrier to dismiss than a treating physician's report.

UM vs. UIM: When Each Applies

Uninsured Motorist (UM) coverage applies when the at-fault driver has no liability insurance at all. The plaintiff's own UM policy steps in as the source of recovery for bodily injury damages. UM is mandatory in most states.

Underinsured Motorist (UIM) coverage applies when the at-fault driver has liability insurance, but the policy limits are insufficient to cover the plaintiff's damages. The plaintiff's UIM policy pays the difference between the at-fault driver's liability limits and the UIM policy limits (minus any amount recovered from the liability carrier).

Example: At-fault driver has $25,000 in liability coverage. Plaintiff's damages are $150,000. Plaintiff's UIM limit is $100,000. After collecting $25,000 from the liability carrier, the plaintiff can collect up to $75,000 from UIM (total recovery capped at $100,000 in most states).

Triggering UIM Coverage

The consent-to-settle issue: collecting from the at-fault driver's liability carrier typically requires the plaintiff to exhaust those limits and obtain UIM carrier consent before settlement. Failure to get consent to settle can void the UIM claim. This is a procedural trap that creates specific coordination requirements for pharmacy lien payment.

The UM/UIM Carrier's Adversarial Posture

UM/UIM carriers are not neutral. They have the same financial incentives as liability carriers: minimize the payout. Common tactics:

IME and peer review. UM/UIM carriers routinely order IMEs and paper peer reviews challenging the necessity of treatment. Pharmacy records are scrutinized: are the medications clinically appropriate? Are there pre-existing conditions that explain the prescriptions?

Surveillance. UM/UIM carriers conduct physical surveillance and social media monitoring to challenge injury severity claims.

EUO (Examination Under Oath). Many UM policies require the plaintiff to submit to an examination under oath about the accident and their injuries. Inconsistencies with the medical record — including prescription history — are exploited.

Comparative analysis. UM/UIM carriers compare the plaintiff's treatment against "expected" treatment for the type of accident, using databases of prior claims to argue that the treatment volume and medication regimen are disproportionate.

Why Pharmacy Records Are Critical in UM/UIM Cases

Pharmacy records in a UM/UIM case perform several functions that are heightened compared to a standard liability case:

Documenting Injury Severity to the Client's Own Insurer

The UM/UIM carrier's core argument is that the injuries are not as severe as claimed. Pharmacy records directly rebut this: a patient being treated with CGRP monoclonal antibodies for post-traumatic migraine, PTSD medication, and neuropathic pain agents has a documented, ongoing, multi-system injury that is hard to minimize.

A 12-month or 18-month pharmacy lien statement — showing continuous prescriptions across multiple injury categories — is objective, third-party documentation of injury duration and severity. It is harder to dismiss than a treating physician's report, which the carrier can attribute to a sympathetic provider.

Establishing a Causation Timeline

Prescriptions that begin immediately after the accident and continue through the case create a causation timeline that is difficult to sever. The carrier cannot argue the injuries were pre-existing if the prescription record shows the medications started after the accident date.

Pharmacy records with clear dates — enrollment date, first dispense date, ongoing refill history — provide this timeline automatically. A well-documented pharmacy lien generates a complete chronological record.

Supporting Non-Economic Damages

UM/UIM claims typically proceed through arbitration or litigation where non-economic damages (pain and suffering) are the primary issue. Pharmacy records document the lived experience of the injury:

• Ongoing prescriptions for chronic pain mean ongoing daily pain
• Sleep medication prescriptions document disrupted sleep
• PTSD medications document psychiatric injury affecting daily function
• Migraine medications document episodic debilitating headaches

The MERIT report translates these prescription records into a clinical narrative — explaining what each medication means in terms of the patient's functional impairment and quality of life. In arbitration, this kind of documentation makes the non-economic damages claim concrete rather than speculative.

[!KEY] In UM/UIM arbitration, the arbitrator is a sophisticated PI professional who understands exactly what a CGRP prescription or PTSD medication regimen means — the MERIT report provides the clinical context that converts a list of drug names into a damages narrative the arbitrator can directly apply.

[!TIP] Include the outstanding pharmacy lien balance in your UIM demand — if it is not documented in the damages calculation before the consent-to-settle decision, it may come as a surprise that reduces your client's net recovery at disbursement.

Consent-to-Settle and Pharmacy Lien Coordination

When settling the liability claim before the UIM claim is resolved, the attorney must:

1. Notify the UIM carrier of the proposed settlement with the liability carrier
2. Obtain consent to settle (or preserve the right to substitute the carrier in, if consent is refused)
3. Address the pharmacy lien in the context of the overall settlement structure

The pharmacy lien creates a complication: if the liability settlement is insufficient to cover the pharmacy lien in full (because the liability limits are low), the remaining lien balance must be addressed in the UIM settlement. The attorney should document the full pharmacy lien balance in the demand to the UIM carrier so it is included in the damages calculation.

Do not settle the UIM claim without accounting for the outstanding pharmacy lien — the client's net recovery will be reduced if the lien comes as a surprise at disbursement.

UM/UIM Arbitration and Pharmacy Records

Most UM/UIM claims proceed through binding arbitration rather than jury trial. Arbitrators are typically experienced PI attorneys or former judges. In arbitration:

• Pharmacy records are admissible as business records. They do not require physician authentication to be admitted.
• MERIT reports provide expert analysis without the cost of a live expert witness. Pharmacists can be retained as expert witnesses if the case warrants, but the MERIT report often provides sufficient clinical support for arbitration.
• The arbitrator is sophisticated. Unlike a lay jury that might be confused by medical terminology, a PI arbitrator understands what a CGRP monoclonal antibody treatment regimen means in terms of injury severity and ongoing treatment burden.

State Variations

Mandatory UM/UIM: Most states require insurers to offer UM/UIM coverage; several require it at specified minimum limits. The minimum limits required vary from $15,000 to $50,000 per person in most states.

Stacking: Some states allow "stacking" — combining UM/UIM limits from multiple vehicles on the policy. If a client has three vehicles insured, they may stack three policies' worth of UIM coverage. State law governs whether stacking is permitted.

Offset rules: Some states require UIM benefits to be offset by the amount recovered from the liability carrier (reducing the UIM payout dollar-for-dollar by the liability recovery). Other states allow recovery of the full UIM limit regardless of the liability payment.

Arbitration mandatory vs. optional: Most states allow UM/UIM arbitration but some require it. Know whether your state mandates arbitration or gives the carrier the right to demand a jury trial.

[!KEY] In states where UM coverage is mandatory but limits are low, the pharmacy lien balance often exceeds the UM policy limits available — knowing the pharmacy lien balance early and including it in all demand correspondence prevents it from appearing as a surprise that reduces the client's net recovery.

For UM/UIM cases requiring pharmacy documentation that will withstand carrier scrutiny, contact LienScripts about enrollment and MERIT documentation.

Related Resources

• Top Adjuster Attacks on Pharmacy Liens — And How to Rebut Them
• When Your Client Has Multiple Insurance Sources: Pharmacy Lien Coordination
• How to Use Pharmacy Records in Your Demand Package